A detailed history of Vr Adviser, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 4,394,527 shares of ORIC stock, worth $42.5 Million. This represents 3.41% of its overall portfolio holdings.

Number of Shares
4,394,527
Previous 4,394,527 -0.0%
Holding current value
$42.5 Million
Previous $60.4 Million 48.58%
% of portfolio
3.41%
Previous 5.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.04 - $16.03 $15.8 Million - $31.5 Million
1,966,142 Added 80.97%
4,394,527 $60.4 Million
Q4 2023

Feb 14, 2024

BUY
$5.41 - $9.43 $1.54 Million - $2.69 Million
285,529 Added 13.32%
2,428,385 $22.3 Million
Q2 2023

Aug 11, 2023

BUY
$4.95 - $8.4 $10.6 Million - $18 Million
2,142,856 New
2,142,856 $16.6 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $383M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.